Also listed on Crimagua Limited, an earlier holder on the record. The recorded assignments below show how it moved.
Term ends Feb 26, 2031 · High confidence
20-year base term ends Oct 17, 2028
Held by Janssen Sciences Ireland Uc
Filed Jun 24, 2010 as application 12/738,396 · Granted May 9, 2017
Base term plus 862 days of patent term adjustment (USPTO delay)
Today
2008
2031
Clock starts
Oct 17, 2008
Oct 17, 2008
Term ends
Feb 26, 2031
Feb 26, 2031
Granted
May 9, 2017
May 9, 2017
base term
patent term adjustment
fee events
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
862
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
None
Terminal disclaimer
No disclaimer on this record.
2 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
5
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
This patent's term runs 862 days past its 20-year base term on prosecution delay. 2 of 3 maintenance fees are paid so far. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Oct 17, 2008, when application PCT/US2008/080382, the earliest non-provisional in its chain, was filed (this one was filed Jun 24, 2010) | Oct 17, 2028 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +862 days, USPTO patent term adjustment record | Feb 26, 2031 | High confidence |
| Terminal disclaimer cap | None on record | no cap applied | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 2 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Feb 26, 2031 | High confidence |
This family
| Application PCT/US2008/080382 | PCT application no patent term | no patent term |
| US 9,644,025 | this patent Feb 2031 | Feb 2031 |
| Application PCT/US2011/033649 | PCT application no patent term | no patent term |
| Application 13/231,903 | Abandoned not computed | not computed |
| US 9,272,030 | In force Nov 2028 | Nov 2028 |
The applications whose file history this site holds. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Aug 10, 2010 Reel 24814, frame 18 | Ekman, Lars; Lieberburg, Ivan; Grundman, Michael; Callaway, James; Gregg, Keith M. | Elan Pharmaceuticals, Inc. | Assignment of Assignor's Interest |
| Aug 10, 2010 Reel 24814, frame 577 | Elan Pharma International Limited | Crimagua Limited; Wyeth | Assignment of Assignor's Interest |
| Aug 10, 2010 Reel 24814, frame 917 | Crimagua Limited | Janssen Alzheimer Immunotherapy; Wyeth | Assignment of Assignor's Interest |
| Aug 10, 2010 Reel 24814, frame 975 | Wyeth | Wyeth LLC | Change of Name |
| Aug 10, 2010 Reel 24815, frame 202 | Black, Ronald; Jacobsen, Jack Steven; Gill, Davinder; Tchistiakova, Lioudmila; Widom, Angela | Wyeth; Elan Pharma International Limited | Assignment of Assignor's Interest |
| Aug 10, 2010 Reel 24816, frame 205 | Elan Pharmaceuticals, Inc. | Elan Pharma International Limited | Assignment of Assignor's Interest |
| Aug 10, 2010 reel/frame not recorded | Jacobsen, Jack Steven; Tchistiakova, Lioudmila; Black, Ronald; Gill, Davinder; Widom, Angela | Wyeth | Assignment of Assignor's Interest |
| Aug 10, 2010 reel/frame not recorded | Jacobsen, Jack Steven; Tchistiakova, Lioudmila; Black, Ronald; Gill, Davinder; Widom, Angela | Elan Pharma International Limited | Assignment of Assignor's Interest |
| Aug 10, 2010 reel/frame not recorded | Elan Pharma International Limited | Crimagua Limited | Assignment of Assignor's Interest |
| Aug 10, 2010 reel/frame not recorded | Elan Pharma International Limited | Wyeth | Assignment of Assignor's Interest |
| Aug 10, 2010 reel/frame not recorded | Crimagua Limited | Janssen Alzheimer Immunotherapy | Assignment of Assignor's Interest |
| Aug 10, 2010 reel/frame not recorded | Crimagua Limited | Wyeth | Assignment of Assignor's Interest |
| Feb 15, 2011 Reel 25800, frame 460 | Wyeth | Wyeth LLC | Corrective Assignment to Correct the Application Number from 12/378396 to 12/738396 Previously Recorded on Reel 024814 Frame 0975. Assignor(S) Hereby Confirms the Change of Name. |
| Feb 27, 2017 Reel 41823, frame 522 | Janssen Alzheimer Immunotherapy | Janssen Sciences Ireland Uc | Change of Name |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
What's changing
Feb 2031
Term ends Feb 26, 2031. Maintenance fees still fall due before then
Note
The 862 days of patent term adjustment (USPTO delay) are read from the USPTO record, not recalculated by us
Citations
25
later US patents cite this one
That is top 25% of utility patents granted in 2017 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.